Clustering data with hclust algorithm for Metabolomics of intensive weight management clinic (IWMC) weight loss (Study ST000744)
C18 NEGATIVE ION MODE (Analysis AN001165)Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 |
---|---|---|---|---|---|---|---|---|---|---|---|
PE 32:1; [M-H]-@6.23 | ME206606 | 1.71 | 0.99 | 2.02 | 0.78 | 0.88 | 0.57 | 0.32 | 0.43 | 0.51 | 1.25 |
PE 33:1; [M-H]-@6.53 | ME206607 | 1.42 | 0.84 | 2.34 | 0.57 | 0.91 | 0.53 | 0.41 | 0.60 | 0.35 | 1.43 |
PE 36:5; [M-H]-@5.94 | ME206619 | 1.23 | 0.67 | 2.14 | 0.85 | 0.67 | 0.93 | 0.63 | 0.93 | 0.45 | 0.70 |
PE 37:6; [M-H]-@5.94 | ME206623 | 1.03 | 0.65 | 2.51 | 0.89 | 0.52 | 0.64 | 0.46 | 0.68 | 0.64 | 0.98 |
PE 34:3; [M-H]-@5.95 | ME206610 | 1.25 | 0.97 | 2.30 | 0.91 | 0.75 | 0.62 | 0.48 | 0.49 | 0.58 | 0.78 |
PE 35:4; [M-H]-@6.04 | ME206613 | 1.10 | 1.25 | 2.24 | 0.84 | 0.80 | 0.56 | 0.49 | 0.43 | 0.67 | 0.86 |
plasmenyl-PE 36:5; [M-H]-@6.27 | ME206665 | 0.73 | 0.57 | 0.93 | 1.07 | 0.97 | 1.00 | 1.23 | 2.02 | 0.78 | 0.73 |
PC 34:5; [M-Ac-H]-@5.14 | ME206577 | 0.97 | 0.30 | 1.15 | 1.21 | 1.16 | 0.62 | 0.67 | 1.88 | 1.17 | 0.64 |
PC 36:6; [M-Ac-H]-@5.48 | ME206587 | 0.72 | 0.53 | 1.22 | 1.44 | 0.93 | 0.75 | 0.66 | 1.91 | 0.69 | 0.65 |
PE 36:6; [M-H]-@5.60 | ME206620 | 0.71 | 1.24 | 1.63 | 0.73 | 0.94 | 0.62 | 1.44 | 0.33 | 0.70 | 1.53 |
PE 37:3; [M-H]-@6.86 | ME206621 | 0.87 | 1.64 | 1.38 | 1.15 | 0.74 | 0.43 | 1.02 | 0.65 | 0.94 | 1.05 |
PE 35:2; [M-H]-@6.68 | ME206612 | 1.18 | 1.60 | 1.08 | 0.66 | 0.55 | 0.77 | 1.74 | 0.71 | 0.72 | 1.59 |
CerP 34:1; [M-H]-@5.83 | ME206545 | 0.88 | 0.91 | 1.03 | 0.96 | 0.82 | 0.87 | 1.17 | 1.00 | 1.24 | 1.28 |
plasmenyl-PE 34:1; [M-H]-@7.15 | ME206661 | 0.70 | 0.88 | 0.82 | 0.96 | 0.98 | 1.02 | 1.50 | 1.12 | 1.11 | 1.14 |
plasmenyl-PE 42:5; [M-H]-@7.85 | ME206675 | 0.93 | 1.00 | 0.99 | 0.84 | 0.71 | 0.99 | 1.57 | 1.17 | 0.98 | 1.14 |
FFA(24:2) | ME206561 | 0.89 | 0.91 | 0.72 | 0.78 | 0.93 | 1.05 | 2.16 | 0.99 | 1.17 | 0.92 |
plasmenyl-PE 40:3; [M-H]-@8.01 | ME206672 | 1.00 | 1.09 | 0.84 | 0.81 | 0.65 | 0.87 | 1.97 | 0.73 | 1.15 | 1.48 |
plasmenyl-PE 40:4; [M-H]-@7.72 | ME206673 | 0.94 | 0.91 | 0.80 | 0.80 | 0.61 | 1.15 | 1.87 | 0.94 | 0.93 | 1.57 |
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.83 | ME206564 | 0.75 | 1.29 | 0.78 | 1.17 | 0.97 | 0.88 | 1.11 | 0.91 | 1.45 | 0.80 |
PC 37:2; [M-Ac-H]-@7.22 | ME206588 | 0.52 | 1.18 | 0.82 | 1.47 | 0.98 | 0.75 | 1.09 | 1.12 | 1.10 | 0.82 |
PA 34:2; [M-H]-@6.26 | ME206566 | 0.93 | 1.64 | 0.76 | 1.15 | 1.04 | 0.94 | 0.86 | 1.02 | 0.94 | 0.83 |
PC 35:1; [M-Ac-H]-@7.04 | ME206578 | 0.83 | 1.46 | 0.97 | 0.93 | 1.17 | 0.96 | 0.82 | 1.01 | 0.89 | 1.00 |
PE 36:2; [M-H]-@6.97 | ME206616 | 1.22 | 1.57 | 1.18 | 0.95 | 1.07 | 0.79 | 0.59 | 0.75 | 0.79 | 1.02 |
PI 34:2; [M-H]-@5.30 | ME206641 | 1.19 | 1.42 | 1.27 | 1.02 | 0.98 | 0.96 | 0.44 | 0.78 | 0.97 | 0.71 |
PI 40:6; [M-H]-@5.83 | ME206649 | 1.08 | 0.79 | 1.27 | 0.79 | 1.21 | 1.08 | 0.57 | 1.12 | 1.28 | 0.62 |
PC 35:5; [M-Ac-H]-@5.51 | ME206581 | 1.03 | 0.71 | 1.16 | 1.24 | 1.14 | 0.43 | 1.11 | 1.15 | 0.76 | 1.08 |
PC 39:6; [M-Ac-H]-@6.40 | ME206598 | 0.79 | 0.61 | 1.22 | 1.02 | 1.22 | 0.94 | 1.13 | 1.10 | 0.72 | 0.92 |
PE 37:5; [M-H]-@6.14 | ME206622 | 0.98 | 0.87 | 1.05 | 0.78 | 1.19 | 1.09 | 0.84 | 1.48 | 0.84 | 0.93 |
PC 39:5; [M-Ac-H]-@6.61 | ME206597 | 0.69 | 0.78 | 0.96 | 1.40 | 1.14 | 0.60 | 1.03 | 1.48 | 1.03 | 0.66 |
PC 36:5; [M-Ac-H]-@5.68 | ME206586 | 0.85 | 0.60 | 1.08 | 1.12 | 0.95 | 1.05 | 0.95 | 1.61 | 0.82 | 0.77 |
PC 38:7; [M-Ac-H]-@5.51 | ME206596 | 0.83 | 0.86 | 1.07 | 1.23 | 0.94 | 0.88 | 0.92 | 1.37 | 0.96 | 0.71 |
FFA(24:3) | ME206562 | 0.98 | 0.56 | 0.71 | 1.11 | 1.02 | 1.43 | 0.71 | 0.90 | 1.27 | 1.26 |
N-(tetracosanoyl)-sphing-4-enine; [M-H]-@8.90 | ME206565 | 0.97 | 0.94 | 0.85 | 1.03 | 1.08 | 1.05 | 0.68 | 0.85 | 1.33 | 1.24 |
PC 40:8; [M-Ac-H]-@5.79 | ME206604 | 1.03 | 1.20 | 0.86 | 0.96 | 0.84 | 0.99 | 0.58 | 1.05 | 1.41 | 1.34 |
PE 38:4; [M-H]-@6.93 | ME206626 | 1.19 | 0.85 | 1.23 | 0.98 | 1.00 | 0.88 | 0.83 | 0.83 | 0.89 | 1.16 |
PG 33:0; [M-H]-@6.08 | ME206637 | 1.43 | 0.83 | 1.15 | 0.95 | 0.77 | 0.98 | 0.81 | 0.94 | 1.03 | 1.14 |
PC 33:1; [M-Ac-H]-@6.43 | ME206571 | 1.40 | 1.27 | 0.97 | 0.93 | 1.02 | 0.96 | 1.05 | 0.84 | 0.88 | 0.79 |
PI 36:4; [M-H]-@5.27 | ME206644 | 1.25 | 1.29 | 0.94 | 0.96 | 1.02 | 1.12 | 0.77 | 0.86 | 0.95 | 0.89 |
FFA(22:0) | ME206555 | 1.32 | 1.00 | 0.89 | 1.01 | 1.10 | 1.00 | 0.83 | 0.99 | 0.86 | 1.04 |
FFA(24:0) | ME206559 | 1.60 | 0.89 | 0.84 | 1.04 | 1.11 | 1.01 | 0.74 | 0.80 | 0.98 | 1.05 |
PE 38:2; [M-H]-@7.50 | ME206624 | 0.83 | 1.06 | 0.89 | 1.46 | 0.75 | 0.85 | 0.71 | 1.20 | 1.08 | 1.01 |
PC 35:3; [M-Ac-H]-@6.10 | ME206580 | 1.04 | 0.90 | 0.84 | 1.34 | 0.82 | 1.06 | 0.91 | 0.82 | 0.98 | 1.17 |
plasmenyl-PE 38:1; [M-H]-@8.22 | ME206666 | 1.12 | 0.83 | 0.96 | 1.34 | 0.65 | 0.81 | 1.02 | 0.90 | 1.07 | 1.26 |
PC 38:4; [M-Ac-H]-@6.73 | ME206593 | 0.83 | 0.69 | 1.11 | 1.32 | 1.11 | 0.92 | 0.75 | 0.90 | 0.92 | 1.01 |
PC 36:4; [M-Ac-H]-@6.09 | ME206585 | 0.79 | 0.65 | 1.18 | 1.14 | 1.12 | 0.92 | 0.68 | 0.88 | 1.23 | 1.05 |
PC 37:6; [M-Ac-H]-@5.79 | ME206590 | 0.81 | 0.71 | 1.18 | 1.12 | 1.01 | 0.93 | 0.67 | 1.07 | 1.21 | 1.00 |
PC 38:6; [M-Ac-H]-@6.01 | ME206595 | 0.74 | 0.63 | 1.02 | 1.09 | 1.09 | 1.04 | 0.88 | 1.33 | 1.04 | 0.98 |
PC 40:6; [M-Ac-H]-@6.69 | ME206602 | 0.73 | 0.60 | 1.06 | 1.11 | 1.14 | 1.00 | 0.79 | 1.42 | 1.00 | 0.93 |
plasmenyl-PE 38:5; [M-H]-@6.74 | ME206670 | 0.80 | 0.88 | 1.01 | 1.21 | 1.12 | 0.84 | 0.89 | 1.06 | 0.98 | 1.01 |
plasmenyl-PE 38:6; [M-H]-@6.51 | ME206671 | 0.80 | 0.86 | 0.94 | 1.16 | 1.22 | 0.89 | 0.85 | 1.24 | 0.99 | 0.89 |
plasmenyl-PE 40:6; [M-H]-@7.17 | ME206674 | 0.77 | 0.76 | 1.02 | 1.11 | 1.22 | 0.86 | 0.98 | 1.16 | 0.99 | 0.96 |
PC 38:5; [M-Ac-H]-@6.37 | ME206594 | 0.75 | 0.65 | 1.03 | 1.24 | 1.02 | 0.92 | 0.89 | 1.17 | 1.05 | 1.05 |
PC 40:7; [M-Ac-H]-@6.22 | ME206603 | 0.71 | 0.79 | 1.05 | 1.23 | 1.03 | 0.83 | 0.75 | 1.12 | 1.13 | 1.15 |
PC 35:2; [M-Ac-H]-@6.56 | ME206579 | 0.86 | 1.09 | 0.97 | 1.10 | 0.98 | 0.80 | 0.98 | 1.08 | 1.03 | 1.16 |
PG 36:1; [M-H]-@6.45 | ME206639 | 0.98 | 0.90 | 1.07 | 1.12 | 1.07 | 0.78 | 0.75 | 1.14 | 1.17 | 0.91 |
PC 38:3; [M-Ac-H]-@7.08 | ME206592 | 1.04 | 1.02 | 1.28 | 0.98 | 1.04 | 0.72 | 0.86 | 1.14 | 0.90 | 0.89 |
CerP 34:2; [M-H]-@5.29 | ME206546 | 0.99 | 1.03 | 1.19 | 1.01 | 0.98 | 0.68 | 0.90 | 1.08 | 1.03 | 1.08 |
PC 36:3; [M-Ac-H]-@6.40 | ME206584 | 1.04 | 0.93 | 1.13 | 1.12 | 1.02 | 0.79 | 0.84 | 0.96 | 1.01 | 1.01 |
PC 33:2; [M-Ac-H]-@5.98 | ME206572 | 1.00 | 1.27 | 0.84 | 1.13 | 0.97 | 0.90 | 0.91 | 0.96 | 1.28 | 0.83 |
PC 34:2; [M-Ac-H]-@6.21 | ME206574 | 1.06 | 1.19 | 0.94 | 1.11 | 1.03 | 0.88 | 0.81 | 0.96 | 1.15 | 0.85 |
PC 37:4; [M-Ac-H]-@6.51 | ME206589 | 0.65 | 1.11 | 0.98 | 1.26 | 1.01 | 0.94 | 0.88 | 1.03 | 1.05 | 0.88 |
PC 34:3; [M-Ac-H]-@5.76 | ME206575 | 0.91 | 0.99 | 1.14 | 1.25 | 0.99 | 0.80 | 0.79 | 1.03 | 0.91 | 0.88 |
PC 38:2; [M-Ac-H]-@7.45 | ME206591 | 1.02 | 0.99 | 1.06 | 1.19 | 0.91 | 0.91 | 0.95 | 1.01 | 0.88 | 0.90 |
plasmenyl-PE 38:2; [M-H]-@7.84 | ME206667 | 0.88 | 1.20 | 0.95 | 1.36 | 1.06 | 0.74 | 0.80 | 1.01 | 0.86 | 0.95 |
PC 36:2; [M-Ac-H]-@6.85 | ME206583 | 0.95 | 1.18 | 0.91 | 1.26 | 1.03 | 0.88 | 0.86 | 1.01 | 0.93 | 0.87 |
PG 36:0; [M-H]-@6.92 | ME206638 | 0.89 | 1.16 | 0.91 | 1.17 | 1.10 | 0.97 | 0.98 | 0.98 | 0.86 | 0.85 |
plasmenyl-PE 42:6; [M-H]-@7.74 | ME206676 | 0.91 | 1.03 | 1.05 | 1.00 | 0.92 | 0.94 | 1.23 | 1.21 | 0.84 | 0.90 |
PE 36:0; [M-H]-@7.84 | ME206614 | 0.92 | 0.88 | 0.95 | 1.11 | 0.88 | 1.00 | 1.15 | 1.00 | 1.27 | 0.85 |
FFA(18:2) | ME206550 | 0.84 | 0.80 | 1.00 | 1.12 | 0.98 | 0.97 | 1.00 | 1.16 | 1.19 | 0.85 |
FFA(18:1) | ME206549 | 0.94 | 0.88 | 1.01 | 1.00 | 1.04 | 1.00 | 1.02 | 1.01 | 1.15 | 0.92 |
FFA(20:0) | ME206551 | 0.98 | 0.84 | 0.98 | 1.08 | 0.95 | 0.98 | 1.01 | 1.10 | 1.06 | 0.98 |
FFA(16:0) | ME206547 | 1.01 | 0.90 | 1.02 | 1.01 | 0.98 | 0.97 | 1.07 | 1.06 | 1.06 | 0.93 |
FFA(18:0) | ME206548 | 1.00 | 0.90 | 1.00 | 1.03 | 0.95 | 0.97 | 1.07 | 1.04 | 1.03 | 0.99 |
FFA(22:3) | ME206558 | 1.12 | 0.71 | 1.01 | 0.91 | 1.21 | 1.12 | 0.89 | 0.91 | 1.05 | 0.97 |
PC 32:0; [M-Ac-H]-@6.62 | ME206568 | 1.16 | 0.81 | 1.05 | 1.00 | 0.99 | 1.03 | 0.87 | 1.01 | 1.14 | 0.85 |
CerP 32:1; [M-H]-@5.11 | ME206544 | 0.81 | 0.87 | 1.22 | 1.21 | 1.25 | 0.93 | 0.69 | 1.11 | 0.67 | 0.76 |
PC 34:4; [M-Ac-H]-@5.53 | ME206576 | 1.00 | 0.76 | 1.33 | 1.24 | 1.15 | 0.75 | 0.48 | 1.17 | 0.74 | 0.88 |
PC 32:2; [M-Ac-H]-@5.59 | ME206570 | 1.04 | 1.11 | 1.08 | 1.37 | 0.99 | 0.75 | 0.67 | 1.08 | 0.80 | 0.77 |
PI 38:5; [M-H]-@5.38 | ME206647 | 0.91 | 1.14 | 1.24 | 1.34 | 0.98 | 0.92 | 0.56 | 0.97 | 0.75 | 0.67 |
PC 30:1; [M-Ac-H]-@5.42 | ME206567 | 1.13 | 1.31 | 1.13 | 1.27 | 1.02 | 0.72 | 0.60 | 1.05 | 0.60 | 0.89 |
PC 36:1; [M-Ac-H]-@7.27 | ME206582 | 1.04 | 1.19 | 1.07 | 1.10 | 1.13 | 0.87 | 0.74 | 1.01 | 0.73 | 0.95 |
PC 32:1; [M-Ac-H]-@6.10 | ME206569 | 1.26 | 1.08 | 1.19 | 1.05 | 1.12 | 0.99 | 0.59 | 0.80 | 0.77 | 0.86 |
PC 34:1; [M-Ac-H]-@6.65 | ME206573 | 1.10 | 1.15 | 1.06 | 0.98 | 1.24 | 0.91 | 0.72 | 0.90 | 0.91 | 0.92 |
PI 40:5; [M-H]-@5.98 | ME206648 | 1.19 | 1.10 | 1.09 | 0.92 | 1.16 | 1.09 | 0.61 | 0.94 | 0.88 | 0.87 |
PC 42:10; [M-Ac-H]-@5.71 | ME206605 | 1.09 | 1.00 | 1.15 | 0.96 | 1.22 | 1.05 | 0.44 | 0.82 | 0.96 | 1.09 |
PI 38:3; [M-H]-@6.15 | ME206645 | 1.06 | 1.15 | 1.03 | 1.08 | 1.22 | 0.99 | 0.42 | 0.86 | 1.00 | 1.00 |
PG 36:2; [M-H]-@6.02 | ME206640 | 1.08 | 0.93 | 1.09 | 1.07 | 1.08 | 0.89 | 0.58 | 0.97 | 1.00 | 1.15 |
PC 40:4; [M-Ac-H]-@7.31 | ME206600 | 1.02 | 1.03 | 1.03 | 1.14 | 1.29 | 0.80 | 0.61 | 0.90 | 0.86 | 1.10 |
PC 40:5; [M-Ac-H]-@7.06 | ME206601 | 0.95 | 1.00 | 1.05 | 1.01 | 1.30 | 0.96 | 0.66 | 0.97 | 0.88 | 1.01 |
PI 38:4; [M-H]-@5.91 | ME206646 | 0.96 | 0.98 | 0.98 | 1.18 | 1.13 | 1.15 | 0.56 | 0.95 | 0.98 | 0.85 |
PI 36:2; [M-H]-@5.93 | ME206643 | 0.97 | 1.16 | 1.16 | 1.25 | 0.93 | 1.00 | 0.53 | 0.83 | 0.96 | 0.84 |
plasmenyl-PE 34:0; [M-H]-@7.20 | ME206660 | 0.99 | 1.27 | 0.99 | 1.19 | 0.96 | 0.91 | 0.70 | 0.86 | 0.99 | 1.02 |
FFA(20:4) Arachidonic acid | ME206554 | 0.82 | 0.65 | 0.81 | 1.02 | 1.38 | 0.93 | 0.89 | 1.32 | 1.02 | 1.17 |
FFA(22:1) | ME206556 | 0.75 | 0.62 | 0.80 | 1.01 | 1.60 | 0.91 | 1.01 | 0.96 | 1.10 | 1.19 |
FFA(24:1) | ME206560 | 0.92 | 0.72 | 0.85 | 0.97 | 1.31 | 0.96 | 1.25 | 0.93 | 1.17 | 0.97 |
FFA(22:2) | ME206557 | 0.94 | 0.91 | 0.98 | 0.93 | 1.34 | 1.09 | 0.74 | 0.94 | 1.15 | 0.85 |
FFA(20:1) | ME206552 | 0.89 | 0.85 | 0.81 | 0.92 | 1.37 | 1.14 | 0.93 | 0.86 | 1.36 | 0.86 |
FFA(20:2) | ME206553 | 0.86 | 0.83 | 0.85 | 1.07 | 1.28 | 1.05 | 0.92 | 1.02 | 1.23 | 0.79 |
PC 40:3; [M-Ac-H]-@7.51 | ME206599 | 0.83 | 0.54 | 1.27 | 0.91 | 1.05 | 0.87 | 0.91 | 0.93 | 1.29 | 1.26 |
lysoPE 20:4; [M-H]-@1.34 | ME206656 | 0.90 | 0.70 | 0.84 | 1.10 | 1.24 | 0.81 | 0.87 | 0.82 | 1.26 | 1.51 |
lysoPE 22:6; [M-H]-@1.28 | ME206658 | 1.03 | 0.57 | 0.86 | 1.09 | 1.12 | 0.97 | 0.70 | 1.17 | 1.31 | 1.22 |
lysoPE 22:5; [M-H]-@1.64 | ME206657 | 1.15 | 0.71 | 1.04 | 1.05 | 1.28 | 0.90 | 0.80 | 0.72 | 0.85 | 1.33 |
plasmenyl-PE 38:3; [M-H]-@7.51 | ME206668 | 0.91 | 0.95 | 1.24 | 0.94 | 1.18 | 0.63 | 0.60 | 0.87 | 1.12 | 1.47 |
plasmenyl-PE 34:3; [M-H]-@6.30 | ME206662 | 0.93 | 0.72 | 1.07 | 1.10 | 1.29 | 0.76 | 0.54 | 1.16 | 0.95 | 1.27 |
plasmenyl-PE 36:1; [M-H]-@7.71 | ME206663 | 0.93 | 0.95 | 1.18 | 1.04 | 1.29 | 0.69 | 0.67 | 0.97 | 0.80 | 1.27 |
plasmenyl-PE 38:4; [M-H]-@7.21 | ME206669 | 0.91 | 0.90 | 1.09 | 1.06 | 1.23 | 0.75 | 0.64 | 1.01 | 0.97 | 1.29 |
plasmenyl-PE 32:1; [M-H]-@6.59 | ME206659 | 1.09 | 0.92 | 0.96 | 1.16 | 1.42 | 0.68 | 0.85 | 0.68 | 1.15 | 0.93 |
N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 | ME206563 | 0.63 | 0.84 | 1.10 | 1.01 | 1.33 | 0.79 | 0.89 | 0.87 | 1.19 | 1.17 |
plasmenyl-PE 36:3; [M-H]-@6.90 | ME206664 | 0.71 | 1.08 | 1.08 | 1.22 | 1.22 | 0.70 | 0.72 | 0.79 | 1.16 | 1.09 |
PS 38:4; [M-H]-@6.03 | ME206650 | 1.47 | 0.66 | 1.61 | 0.65 | 0.77 | 0.85 | 0.73 | 1.18 | 0.51 | 1.49 |
PE 39:6; [M-H]-@6.49 | ME206631 | 1.10 | 0.69 | 1.16 | 0.97 | 0.80 | 0.82 | 0.90 | 1.27 | 0.90 | 1.45 |
PE 40:8; [M-H]-@5.91 | ME206636 | 0.73 | 0.69 | 1.52 | 1.00 | 0.65 | 0.74 | 0.93 | 1.07 | 0.72 | 1.73 |
PE 35:1; [M-H]-@7.07 | ME206611 | 0.91 | 1.48 | 1.32 | 0.95 | 0.86 | 0.75 | 0.47 | 0.83 | 0.71 | 1.65 |
PE 39:4; [M-H]-@7.24 | ME206630 | 1.04 | 0.48 | 1.33 | 1.16 | 1.01 | 0.88 | 0.44 | 0.70 | 1.07 | 1.45 |
PE 33:2; [M-H]-@6.05 | ME206608 | 1.22 | 1.01 | 1.73 | 1.20 | 0.63 | 0.76 | 0.66 | 0.60 | 0.57 | 1.00 |
PI 36:1; [M-H]-@6.34 | ME206642 | 1.02 | 1.03 | 1.48 | 0.99 | 1.18 | 0.86 | 0.49 | 0.69 | 0.83 | 0.95 |
PE 40:5; [M-H]-@7.14 | ME206633 | 1.17 | 0.94 | 1.58 | 0.81 | 1.10 | 0.76 | 0.51 | 1.06 | 0.73 | 1.04 |
PE 40:6; [M-H]-@6.88 | ME206634 | 1.10 | 0.83 | 1.50 | 0.85 | 1.08 | 0.94 | 0.61 | 1.05 | 0.84 | 0.85 |
PE 38:7; [M-H]-@5.73 | ME206629 | 0.92 | 0.86 | 1.77 | 0.84 | 0.79 | 0.90 | 0.50 | 0.90 | 0.75 | 1.31 |
PE 40:7; [M-H]-@6.36 | ME206635 | 0.90 | 0.73 | 1.54 | 1.05 | 0.83 | 0.90 | 0.71 | 0.91 | 0.78 | 1.21 |
PE 34:1; [M-H]-@6.84 | ME206609 | 1.41 | 1.17 | 1.42 | 0.83 | 0.88 | 0.84 | 0.73 | 0.69 | 0.67 | 1.24 |
PE 36:3; [M-H]-@6.53 | ME206617 | 1.25 | 1.23 | 1.32 | 1.04 | 0.93 | 0.68 | 0.76 | 0.63 | 0.75 | 1.24 |
PE 38:6; [M-H]-@6.11 | ME206628 | 1.18 | 0.82 | 1.59 | 0.88 | 0.86 | 0.86 | 0.57 | 0.81 | 0.93 | 1.19 |
PE 36:4; [M-H]-@6.21 | ME206618 | 1.25 | 0.93 | 1.54 | 0.87 | 0.99 | 0.75 | 0.70 | 0.69 | 0.82 | 1.16 |
PE 40:4; [M-H]-@7.40 | ME206632 | 1.25 | 0.84 | 1.51 | 1.04 | 0.87 | 0.80 | 0.69 | 0.71 | 0.76 | 1.13 |
PE 36:1; [M-H]-@7.42 | ME206615 | 1.06 | 1.07 | 1.41 | 1.01 | 0.96 | 0.83 | 0.58 | 0.74 | 0.75 | 1.26 |
PE 38:3; [M-H]-@7.22 | ME206625 | 1.22 | 0.99 | 1.51 | 0.85 | 1.01 | 0.72 | 0.54 | 0.70 | 0.81 | 1.42 |
PE 38:5; [M-H]-@6.51 | ME206627 | 1.17 | 0.90 | 1.56 | 0.96 | 0.97 | 0.78 | 0.50 | 0.64 | 0.76 | 1.37 |
lysoPE 16:0; [M-H]-@1.66 | ME206651 | 1.06 | 0.72 | 0.80 | 0.97 | 1.07 | 0.73 | 0.96 | 1.20 | 0.95 | 1.87 |
lysoPE 18:0; [M-H]-@2.42 | ME206652 | 0.91 | 0.55 | 0.82 | 1.03 | 0.89 | 0.66 | 0.88 | 1.43 | 0.90 | 2.30 |
lysoPE 18:1; [M-H]-@1.82 | ME206653 | 0.91 | 0.98 | 0.79 | 1.01 | 1.41 | 0.73 | 0.69 | 0.72 | 0.98 | 1.93 |
lysoPE 18:2; [M-H]-@1.37 | ME206654 | 1.13 | 1.20 | 0.68 | 1.07 | 1.31 | 0.75 | 0.73 | 0.79 | 1.16 | 1.43 |
lysoPE 20:3; [M-H]-@1.63 | ME206655 | 1.31 | 0.92 | 0.94 | 0.97 | 1.49 | 0.58 | 0.48 | 0.90 | 1.01 | 1.46 |
Factors:
F1 | Gender:female | Glycemic status:Diabetic | Neuropathy:Neuropathy |
F2 | Gender:female | Glycemic status:Diabetic | Neuropathy:no neuropathy |
F3 | Gender:female | Glycemic status:Pre-diabetic | Neuropathy:Neuropathy |
F4 | Gender:female | Glycemic status:Pre-diabetic | Neuropathy:no neuropathy |
F5 | Gender:male | Glycemic status:Diabetic | Neuropathy:Neuropathy |
F6 | Gender:male | Glycemic status:Diabetic | Neuropathy:no neuropathy |
F7 | Gender:male | Glycemic status:Normoglycemic | Neuropathy:Neuropathy |
F8 | Gender:male | Glycemic status:Normoglycemic | Neuropathy:no neuropathy |
F9 | Gender:male | Glycemic status:Pre-diabetic | Neuropathy:Neuropathy |
F10 | Gender:male | Glycemic status:Pre-diabetic | Neuropathy:no neuropathy |